Synovial Fluid Withdrawal or PRP Injection For Acute ACL Tears and Cytokines
Does Arthrocentesis and PRP For Acute ACL Tears With Hemarthrosis Decrease Inflammatory Cytokines At Time Of Surgery: A Prospective Randomized Control Trial (RCT)
1 other identifier
interventional
99
1 country
1
Brief Summary
The purpose of this study is to determine what effects the withdrawal of excess knee joint fluid or the injection of a factor from the blood has on swelling after a sudden anterior cruciate ligament (ACL) rupture of the knee.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2025
CompletedFirst Posted
Study publicly available on registry
August 26, 2025
CompletedStudy Start
First participant enrolled
May 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2028
February 12, 2026
February 1, 2026
2.4 years
August 19, 2025
February 11, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Concentration of Collagen Type II Cytokine
Breakdown cytokine found in damaged cartilage
Enrollment up to surgery
Study Arms (3)
Two Synovial Fluid Withdrawals
ACTIVE COMPARATORSubjects randomized to Arm 1 will have 2 synovial fluid withdrawals; one at the preoperative clinic visit and one at the time of surgery
Platelet-Rich Plasma (PRP) and Two Synovial Fluid Withdrawals
EXPERIMENTALSubjects randomized to ARM 2 will have 2 synovial fluid withdrawals one at the preoperative visit and one at the time of surgery. Platelet-Rich Plasma (PRP) preparation and injection will happen at the preoperative clinic visit.
3mL Synovial Fluid Withdrawal and Synovial Fluid Withdrawal at the Time of Surgery
OTHERSubjects randomized to Arm 3 will have 3mL withdrawal of synovial fluid at the preoperative visit and 1 synovial fluid withdrawal at the time of surgery
Interventions
Synovial Fluid withdrawal at the preoperative clinic visit
Platelet-Rich Plasma (PRP) preparation and injection
Synovial fluid withdrawal at the time of surgery
3mL synovial fluid withdrawn at the preoperative visit
Eligibility Criteria
You may qualify if:
- Age 18 - 50
- English-speaking
- Clinical evidence of ACL rupture with swelling
- Participant must be undergoing ACL reconstruction surgery
You may not qualify if:
- Age \<18 or \>50
- Presentation \>3 weeks after initial injury
- Previous traumatic ipsilateral (same side) knee injury consistent with chronic ACL tear or prior ACL surgery
- \> Kellgren-Lawrence grade 2 changes on preoperative x-ray
- History of hemophilia or inflammatory arthropathy (e.g., rheumatoid arthritis)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rush University Medical Center
Chicago, Illinois, 60612, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adam Yanke, MD, PhD
Associate Professor and Surgeon
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2025
First Posted
August 26, 2025
Study Start
May 1, 2026
Primary Completion (Estimated)
October 1, 2028
Study Completion (Estimated)
December 1, 2028
Last Updated
February 12, 2026
Record last verified: 2026-02